Your browser doesn't support javascript.
loading
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
Kaufman, Jonathan L; Mina, Roberto; Shah, Jatin J; Laubach, Jacob P; Nooka, Ajay K; Lewis, Colleen; Gleason, Charise; Sharp, Cathy; Harvey, R Donald; Heffner, Leonard T; Richardson, Paul; Lonial, Sagar; Orlowski, Robert Z.
Afiliación
  • Kaufman JL; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Mina R; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA. Electronic address: roberto.mina.rm@gmail.com.
  • Shah JJ; Karyopharm Therapeutics, Newton, MA.
  • Laubach JP; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.
  • Nooka AK; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Lewis C; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Gleason C; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Sharp C; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Harvey RD; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Heffner LT; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Richardson P; LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.
  • Lonial S; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX.
Clin Lymphoma Myeloma Leuk ; 20(12): 797-803, 2020 12.
Article en En | MEDLINE | ID: mdl-32819881

Texto completo: 1 Colección: 01-internacional Asunto principal: Dexametasona / Bortezomib / Lenalidomida / Vorinostat / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Gabón

Texto completo: 1 Colección: 01-internacional Asunto principal: Dexametasona / Bortezomib / Lenalidomida / Vorinostat / Mieloma Múltiple Tipo de estudio: Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Gabón